Botanical Drug Approval Lower Efficacy Standard Endorsed By Purdue's Tyler
This article was originally published in The Tan Sheet
Executive Summary
FDA should require less stringent efficacy standards for OTC botanical drug products than are necessary for synthetic drugs, Purdue University's Varro Tyler, PhD, suggested at Nutracon 2001 in San Diego July 9.
You may also be interested in...
Herbal Medicines Expert Tyler Dies At Age 74
The dietary supplement industry has lost one of its staunchest supporters and most vocal critics with the death of Varro Tyler, PhD, on Aug. 22 at St. Elizabeth's Hospital in Lafayette, Ind. He was 74.
Herbal Medicines Expert Tyler Dies At Age 74
The dietary supplement industry has lost one of its staunchest supporters and most vocal critics with the death of Varro Tyler, PhD, on Aug. 22 at St. Elizabeth's Hospital in Lafayette, Ind. He was 74.
Herbal Medicines Expert Tyler Dies At Age 74
The dietary supplement industry has lost one of its staunchest supporters and most vocal critics with the death of Varro Tyler, PhD, on Aug. 22 at St. Elizabeth's Hospital in Lafayette, Ind. He was 74.